Kosten, T., Oliveto, A., Feingold, A., Poling, J., Sevarino, K., Cance-Katz, E., et al. (2003). Desipramine
and contingency management for cocaine and opiate dependence in buprenorphine maintained
patients. Drug & Alcohol Dependence, 70(3), 315-325.
Krahn, G., Deck, D., Gabriel, R., & Farrell, N. (2007). A population-based study on substance abuse
treatment for adults with disabilities: Access, utilization, and treatment outcomes. American Journal
of Drug & Alcohol Abuse, 33(6), 791-798.
Krahn, G., Farrell, N., Gabriel, R. M., & Deck, D. (2006). Access barriers to substance abuse treatment
for persons with disabilities: An exploratory study. Journal of Substance Abuse Treatment, 31(4),
375-384.
Krampe, H., Stawicki, S., Wagner, T., Bartels, C., Aust, C., Ruther, E., et al. (2006). Follow-up of 180
alcoholic patients for up to 7 years after outpatient treatment: Impact of alcohol deterrents on
outcome. Alcoholism: Clinical & Experimental Research, 30(1), 86-95.
Kranzler, H. R., Kadden, R. M., Babor, T. F., Tennen, H., & Rounsaville, B. J. (1996). Validity of the
SCID in substance abuse patients. Addiction, 91(6), 859-868.
Kranzler, H. R., Modesto-Lowe, V., & Van, K. J. (2000). Naltrexone vs. nefazodone for treatment of
alcohol dependence: A placebo-controlled trial. Neuropsychopharmacology, 22(5), 493-503.
Kranzler, H. R., Montejano, L. B., Stephenson, J. J., Wang, S., & Gastfriend, D. R. (2010). Effects of
naltrexone treatment for alcohol-related disorders on healthcare costs in an insured population.
Alcoholism: Clinical & Experimental Research, 34(6), 1090-1097.
Kranzler, H. R., Pierucci-Lagha, A., Feinn, R., & Hernandez-Avila, C. (2003). Effects of ondansetron in
early- versus late-onset alcoholics: A prospective, open-label study. Alcoholism: Clinical &
Experimental Research, 27(7), 1150-1155.
Kraus, M. L., Alford, D. P., Kotz, M. M., Levounis, P., Mandell, T. W., Meyer, M., et al. (2011).
Statement of the American Society of Addiction Medicine Consensus Panel on the use of
buprenorphine in office-based treatment of opioid addiction. Journal of Addiction Medicine, 5(4),
254-263.
Kraybill, K., Zerger, S., & National Health Care for the Homeless Council. (2003). Providing treatment
for homeless people with substance use disorders: Case studies of six programs. [Online]. Retrieved
February 6, 2012 from http://www.nhchc.org.
Kreek, M. J., Nielsen, D. A., Butelman, E. R., & LaForge, K. S. (2005). Genetic influences on
impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction. Nature
Neuroscience, 8(11), 1450-1457.
Kreitzer, M. J., Kligler, B., & Meeker, W. C. (2009). Health professions education and integrative health
care. [Online]. Retrieved March 1, 2012 from http://www.iom.edu.
Kremer, D., Malkin, M. J., & Benshoff, J. J. (1995). Physical activity programs offered in substance
abuse treatment facilities. Journal of Substance Abuse Treatment, 12(5), 327-333.
Krisberg, B. (1998). Substance abuse and the juvenile justice system: A paper presented at the Juvenile
Justice & Substance Abuse national Planning meeting sponsored by the Robert Wood Johnson
Foundation. Annapolis, MD: National Council on Crime and Delinquency.
Krishnamoorthy, S., Lip, G. Y. J., & Lane, D. A. (2009). Alcohol and illicit drug use as precipitants of
atrial fibrillation in young adults: A case series and literature review. American Journal of Medicine,
122 (9), 851-856.